nodes	percent_of_prediction	percent_of_DWPC	metapath
Fulvestrant—ESRRA—Nuclear Receptors—NR5A1—adrenal gland cancer	0.0513	0.0718	CbGpPWpGaD
Fulvestrant—ESRRA—Nuclear Receptor transcription pathway—NR5A1—adrenal gland cancer	0.0405	0.0567	CbGpPWpGaD
Fulvestrant—ESR2—Ovarian Infertility Genes—NR5A1—adrenal gland cancer	0.0374	0.0524	CbGpPWpGaD
Fulvestrant—ESR2—Nuclear Receptors—NR5A1—adrenal gland cancer	0.0326	0.0457	CbGpPWpGaD
Fulvestrant—NR1H4—adrenal cortex—adrenal gland cancer	0.0318	0.111	CbGeAlD
Fulvestrant—NR1H4—Nuclear Receptor transcription pathway—NR5A1—adrenal gland cancer	0.0296	0.0414	CbGpPWpGaD
Fulvestrant—EPHX2—adrenal cortex—adrenal gland cancer	0.0278	0.0972	CbGeAlD
Fulvestrant—ESRRA—Organelle biogenesis and maintenance—MRPL48—adrenal gland cancer	0.0265	0.0371	CbGpPWpGaD
Fulvestrant—ESR2—Nuclear Receptor transcription pathway—NR5A1—adrenal gland cancer	0.0258	0.0361	CbGpPWpGaD
Fulvestrant—NR1H4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.0249	0.0348	CbGpPWpGaD
Fulvestrant—ESRRA—adrenal cortex—adrenal gland cancer	0.0243	0.0852	CbGeAlD
Fulvestrant—NR1H4—adrenal gland—adrenal gland cancer	0.0229	0.0803	CbGeAlD
Fulvestrant—EPHX2—pituitary gland—adrenal gland cancer	0.0224	0.0786	CbGeAlD
Fulvestrant—CYP3A4—urine—adrenal gland cancer	0.021	0.0737	CbGeAlD
Fulvestrant—ESRRA—cardiac atrium—adrenal gland cancer	0.0201	0.0704	CbGeAlD
Fulvestrant—EPHX2—adrenal gland—adrenal gland cancer	0.02	0.0702	CbGeAlD
Fulvestrant—ESRRA—pituitary gland—adrenal gland cancer	0.0196	0.0688	CbGeAlD
Fulvestrant—ESRRA—adrenal gland—adrenal gland cancer	0.0175	0.0615	CbGeAlD
Fulvestrant—ESR1—Nuclear Receptors—NR5A1—adrenal gland cancer	0.0165	0.023	CbGpPWpGaD
Fulvestrant—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.0143	0.02	CbGpPWpGaD
Fulvestrant—NR1H4—Endogenous sterols—POMC—adrenal gland cancer	0.0134	0.0187	CbGpPWpGaD
Fulvestrant—ESRRA—PPARA activates gene expression—MED12—adrenal gland cancer	0.0132	0.0184	CbGpPWpGaD
Fulvestrant—ESR1—Nuclear Receptor transcription pathway—NR5A1—adrenal gland cancer	0.013	0.0182	CbGpPWpGaD
Fulvestrant—ESRRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—adrenal gland cancer	0.0129	0.018	CbGpPWpGaD
Fulvestrant—ESR2—gonad—adrenal gland cancer	0.0121	0.0423	CbGeAlD
Fulvestrant—ESR2—pituitary gland—adrenal gland cancer	0.0118	0.0413	CbGeAlD
Fulvestrant—ESR1—Estrogen signaling pathway—PRKACA—adrenal gland cancer	0.0108	0.0151	CbGpPWpGaD
Fulvestrant—ESR2—Plasma membrane estrogen receptor signaling—IGF1R—adrenal gland cancer	0.0106	0.0149	CbGpPWpGaD
Fulvestrant—ESR2—adrenal gland—adrenal gland cancer	0.0105	0.0369	CbGeAlD
Fulvestrant—EPHX2—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00983	0.0138	CbGpPWpGaD
Fulvestrant—NR1H4—PPARA activates gene expression—MED12—adrenal gland cancer	0.00962	0.0135	CbGpPWpGaD
Fulvestrant—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—adrenal gland cancer	0.00942	0.0132	CbGpPWpGaD
Fulvestrant—ESRRA—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—adrenal gland cancer	0.00888	0.0124	CbGpPWpGaD
Fulvestrant—ESR1—Estrogen signaling pathway—GNAS—adrenal gland cancer	0.00874	0.0122	CbGpPWpGaD
Fulvestrant—ESR1—gonad—adrenal gland cancer	0.00828	0.029	CbGeAlD
Fulvestrant—ESR1—pituitary gland—adrenal gland cancer	0.00808	0.0283	CbGeAlD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.00777	0.0109	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.00723	0.0101	CbGpPWpGaD
Fulvestrant—ESR1—adrenal gland—adrenal gland cancer	0.00721	0.0253	CbGeAlD
Fulvestrant—ESRRA—Generic Transcription Pathway—NR5A1—adrenal gland cancer	0.007	0.0098	CbGpPWpGaD
Fulvestrant—ESR1—LKB1 signaling events—PRKACA—adrenal gland cancer	0.00653	0.00915	CbGpPWpGaD
Fulvestrant—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.0065	0.0091	CbGpPWpGaD
Fulvestrant—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—adrenal gland cancer	0.00649	0.00908	CbGpPWpGaD
Fulvestrant—NR1H4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00622	0.00871	CbGpPWpGaD
Fulvestrant—ESR1—Estrogen signaling pathway—BRAF—adrenal gland cancer	0.00581	0.00813	CbGpPWpGaD
Fulvestrant—ESR1—Plasma membrane estrogen receptor signaling—IGF1R—adrenal gland cancer	0.00537	0.00751	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—NR5A1—adrenal gland cancer	0.00511	0.00716	CbGpPWpGaD
Fulvestrant—NR1H4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00504	0.00706	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00462	0.00647	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.00446	0.00625	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—NR5A1—adrenal gland cancer	0.00445	0.00623	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00442	0.00619	CbGpPWpGaD
Fulvestrant—ESRRA—Generic Transcription Pathway—MED12—adrenal gland cancer	0.00421	0.00589	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—SDHB—adrenal gland cancer	0.0041	0.00574	CbGpPWpGaD
Fulvestrant—ESRRA—Generic Transcription Pathway—MEN1—adrenal gland cancer	0.00402	0.00563	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.00392	0.00549	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.00364	0.0051	CbGpPWpGaD
Fulvestrant—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.00356	0.00498	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—CDC42—adrenal gland cancer	0.00355	0.00497	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00354	0.00495	CbGpPWpGaD
Fulvestrant—ESR1—FOXM1 transcription factor network—RB1—adrenal gland cancer	0.00353	0.00494	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—NR5A1—adrenal gland cancer	0.00337	0.00472	CbGpPWpGaD
Fulvestrant—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—adrenal gland cancer	0.00335	0.00469	CbGpPWpGaD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.00328	0.00459	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—SDHB—adrenal gland cancer	0.00328	0.00459	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00323	0.00452	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.00313	0.00438	CbGpPWpGaD
Fulvestrant—ESR1—FOXM1 transcription factor network—CDKN2A—adrenal gland cancer	0.0031	0.00434	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of Telomerase—TERT—adrenal gland cancer	0.00308	0.00431	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—MED12—adrenal gland cancer	0.00307	0.0043	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—MEN1—adrenal gland cancer	0.00294	0.00411	CbGpPWpGaD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	0.00269	0.00377	CbGpPWpGaD
Fulvestrant—ESR1—ATF-2 transcription factor network—RB1—adrenal gland cancer	0.00269	0.00376	CbGpPWpGaD
Fulvestrant—NR1H4—Biological oxidations—POMC—adrenal gland cancer	0.00268	0.00375	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—MED12—adrenal gland cancer	0.00268	0.00375	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—RRM1—adrenal gland cancer	0.00264	0.0037	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—SDHD—adrenal gland cancer	0.00264	0.0037	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00258	0.00362	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00258	0.00361	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—MEN1—adrenal gland cancer	0.00256	0.00358	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—BAD—adrenal gland cancer	0.00248	0.00347	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—NR5A1—adrenal gland cancer	0.00246	0.00345	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—SDHB—adrenal gland cancer	0.0024	0.00335	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.00233	0.00326	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.00225	0.00315	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—NR5A1—adrenal gland cancer	0.00225	0.00314	CbGpPWpGaD
Fulvestrant—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00215	0.003	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—NR5A1—adrenal gland cancer	0.00214	0.003	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—RRM1—adrenal gland cancer	0.00211	0.00296	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—SDHD—adrenal gland cancer	0.00211	0.00296	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—CDKN2A—adrenal gland cancer	0.00206	0.00288	CbGpPWpGaD
Fulvestrant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00204	0.00286	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—CDC42—adrenal gland cancer	0.00203	0.00284	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—MED12—adrenal gland cancer	0.00203	0.00283	CbGpPWpGaD
Fulvestrant—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—adrenal gland cancer	0.002	0.00279	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—MED12—adrenal gland cancer	0.00197	0.00276	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—MEN1—adrenal gland cancer	0.00194	0.00271	CbGpPWpGaD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.00191	0.00267	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00188	0.00264	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.0018	0.00252	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00179	0.00251	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.00176	0.00246	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—CTNNB1—adrenal gland cancer	0.00172	0.00241	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.00171	0.00239	CbGpPWpGaD
Fulvestrant—ESR1—LKB1 signaling events—TP53—adrenal gland cancer	0.00169	0.00237	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.00158	0.00221	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—MED12—adrenal gland cancer	0.00157	0.0022	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—SDHD—adrenal gland cancer	0.00154	0.00216	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—RRM1—adrenal gland cancer	0.00154	0.00216	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.00153	0.00214	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—MED12—adrenal gland cancer	0.00148	0.00207	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00145	0.00203	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PRKACA—adrenal gland cancer	0.00144	0.00201	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00143	0.002	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—BAD—adrenal gland cancer	0.00142	0.00198	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—MEN1—adrenal gland cancer	0.00141	0.00198	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—BAD—adrenal gland cancer	0.00141	0.00197	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.00141	0.00197	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.0014	0.00197	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of Telomerase—EGFR—adrenal gland cancer	0.0014	0.00196	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—MED12—adrenal gland cancer	0.00135	0.00189	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—MEN1—adrenal gland cancer	0.00129	0.00181	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—BRAF—adrenal gland cancer	0.00129	0.0018	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—MED12—adrenal gland cancer	0.00129	0.0018	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—RB1—adrenal gland cancer	0.00127	0.00177	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—MEN1—adrenal gland cancer	0.00123	0.00172	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.00121	0.0017	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.00117	0.00164	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—GNAS—adrenal gland cancer	0.00116	0.00163	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—MED12—adrenal gland cancer	0.00115	0.00161	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PRKACA—adrenal gland cancer	0.00115	0.00161	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—TP53—adrenal gland cancer	0.00115	0.0016	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—ABCB1—adrenal gland cancer	0.00114	0.0016	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.00112	0.00157	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—NR5A1—adrenal gland cancer	0.00108	0.00151	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.00103	0.00144	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.00102	0.00143	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—CTNNB1—adrenal gland cancer	0.000932	0.0013	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GNAS—adrenal gland cancer	0.000931	0.0013	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—ABCB1—adrenal gland cancer	0.000914	0.00128	CbGpPWpGaD
Fulvestrant—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00089	0.00125	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.000863	0.00121	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PRKACA—adrenal gland cancer	0.000839	0.00117	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.00082	0.00115	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GNRHR—adrenal gland cancer	0.000804	0.00113	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—POMC—adrenal gland cancer	0.000784	0.0011	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.000772	0.00108	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000748	0.00105	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—EGFR—adrenal gland cancer	0.000738	0.00103	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—EGFR—adrenal gland cancer	0.000734	0.00103	CbGpPWpGaD
Fulvestrant—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000722	0.00101	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000703	0.000984	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GNAS—adrenal gland cancer	0.00068	0.000952	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ABCB1—adrenal gland cancer	0.000668	0.000934	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—MED12—adrenal gland cancer	0.00065	0.00091	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—POMC—adrenal gland cancer	0.000627	0.000877	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PTGS2—adrenal gland cancer	0.000625	0.000875	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—MEN1—adrenal gland cancer	0.000621	0.000869	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	0.00062	0.000867	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.000612	0.000856	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.000514	0.000719	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PTGS2—adrenal gland cancer	0.0005	0.0007	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000482	0.000674	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—POMC—adrenal gland cancer	0.000458	0.000641	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000441	0.000617	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TSHR—adrenal gland cancer	0.000429	0.000601	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MEN1—adrenal gland cancer	0.000404	0.000565	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000383	0.000537	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PTGS2—adrenal gland cancer	0.000365	0.000511	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.000343	0.00048	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000308	0.000431	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CDC42—adrenal gland cancer	0.000261	0.000366	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IGF2—adrenal gland cancer	0.000252	0.000353	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GNAS—adrenal gland cancer	0.00025	0.00035	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000244	0.000341	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000221	0.000309	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000221	0.000309	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TERT—adrenal gland cancer	0.00021	0.000294	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—BAD—adrenal gland cancer	0.000182	0.000255	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—POMC—adrenal gland cancer	0.000168	0.000235	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—BRAF—adrenal gland cancer	0.000166	0.000232	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000165	0.000231	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.00012	0.000168	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00012	0.000168	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GNAS—adrenal gland cancer	9.74e-05	0.000136	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	9.56e-05	0.000134	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—EGFR—adrenal gland cancer	9.51e-05	0.000133	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TP53—adrenal gland cancer	7.99e-05	0.000112	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—POMC—adrenal gland cancer	6.56e-05	9.18e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	5.23e-05	7.32e-05	CbGpPWpGaD
